Tamiflu news from FiercePharma
NewsALSO NOTED: Appeals court overturns $32M Vioxx award; One-drug stockpiles 'not enough' for pandemic flu;
> A Texas appeals court overturned a Vioxx jury verdict, ruling in favor of Merck and negating damages originally set at $32 million. Judges said there was "insufficient evidence" supporting the Read more...
ALSO NOTED: Squeaking hip devices worry patients, docs; Biotech M&A has yet to reach its peak;
> Replacement hips made with ceramic parts are squeaking in certain patients, some of which have sued Stryker; the company says the noisy side effect happens in less than 1 percent of implants. Read more...
Under pharma earnings, basic problems
You've heard of see-through buildings. How about see-through pharma earnings? Though drug makers have been reporting increases to their bottom lines, investors are looking past the foreign-currency Read more...
Roche warns of Tamiflu psych effects
After some arm-twisting from the FDA, Roche has added stronger warnings to its Tamiflu label. In a Dear Healthcare Professional letter, the company cautioned doctors about the sometimes-fatal Read more...
Tamiflu resistant to seasonal strains
Roche's Tamiflu engine is skipping a few beats. Some seasonal flu strains circulating in Europe are "significantly" resistant to the anti-influenza med, stockpiled around the world as insurance Read more...
Drug name psychology, or the power of Z
You know about those product-naming experts who charge hundreds of thousands for just the right combinations of vowels and consonants. Well, the Associated Press today draws the curtain aside to Read more...
New drug warnings poised for rollout
New warnings and warning recommendations are flying out of the FDA this week like geese flying south for the winter, partly because of an FDA advisory panel is meeting. Here's the latest:Committee Read more...
ALSO NOTED: Merck plots $295 million vaccine plant; Roche agrees to new Tamiflu warning;
> Merck is stepping up its presence on the Emerald Isle. The drug maker plans to invest $295 million in a new vaccine-production plant in Carlow, Ireland, creating 170 jobs in the process. The new Read more...
More studies needed for pediatric doses
All the debate over the safety of kids' drugs lately--from over-the-counter cold meds to Read more...
FDA does a triple-take on Tamiflu
Speaking of pediatric safety, the FDA also plans to review Roche's Tamiflu and GlaxoSmithKline's Relenza at its advisory committee confab Nov. 27-28. At issue: the anti-influenza drugs' potential Read more...
| Press ReleasesPRESS RELEASE: Supply Plan of the Anti-Influenza Drug Tamiflu for the 2007-2008 Season Supply Plan of the Anti-Influenza Drug Tamiflu for the 2007-2008 Season November 5, 2007 - Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President Osamu Nagayama (hereafter, Chugai)] Read more... PRESS RELEASE: New child sized Tamiflu capsules receive European approval New child sized Tamiflu capsules receive European approval Smaller strength capsules provide convenient alternative for management of seasonal and pandemic influenza in children Roche announced Read more... |
Get more Tamiflu coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight